Dr  Varsha Naidu

Dr Varsha Naidu

Post Doctoral Researcher

School of Environmental and Life Sciences

Career Summary

Biography

Biography

Dr. Varsha Naidu earned her PhD from Macquarie University in 2021, with the Vice-chancellor’s Commendation for Academic Excellence under the guidance of Distinguished Professor Ian Paulsen. Her doctoral work delved into the molecular adaptations of a highly drug resistant hospital pathogen, Acinetobacter baumannii, and the role of multidrug efflux transport systems in pathogenic bacteria. Currently, as a Postdoctoral Fellow at the School of Environmental and Life Sciences in Associate Professor Karl Hassan’s lab, her research focusses on integrating functional and comparative genomics with molecular biology, protein engineering and biochemistry.

Research focus

Varsha’s research interest delves deep into three distinct focal areas. These include (1) identifying novel enzymes that play a crucial role in the catabolism of persistent pollutants, such as polycyclic aromatic hydrocarbons (PAHs), in the metabolically affluent Rhodococcus species for bioremediation purposes; (2) utilising coevolutionary methods to engineer membrane-embedded transport proteins for industrial applications and to decipher the evolutionary trajectory of these proteins (3) investigating molecular adaptations of antimicrobial resistant Acinetobacter baumannii, which has led to its success in a nosocomial environment.

Blog: https://microbiologysociety.org/blog/plasmid-encoded-efflux-pumps-empowering-acinetobacter-in-the-battle-against-antimicrobial-resistance.html

 Expertise for collaboration

  • Computational biology - phylogenetics, multiomics, WGCNA, systems biology and highly experienced in transcriptomics data analysis
  • Protein Chemistry - engineering, purification, characterisation and proteomics
  • Molecular Biology - genetic manipulation (cloning, KOs and nucleic acid extractions)
  • Other - Transposon Directed Insertion Site (TraDIS) sequencing, Electron Microscopy (TEM & SEM) and radioligand assays

Qualifications

  • Master of Research, Macquarie University

Keywords

  • Antimicrobial Resistance
  • Functional Genomics
  • Microbial Genomics
  • Molecular Microbiology
  • Multidrug Transporters
  • Pathogens

Fields of Research

Code Description Percentage
310299 Bioinformatics and computational biology not elsewhere classified 30
310704 Microbial genetics 40
310199 Biochemistry and cell biology not elsewhere classified 30

Professional Experience

UON Appointment

Title Organisation / Department
Post Doctoral Researcher University of Newcastle
School of Environmental and Life Sciences
Australia

Academic appointment

Dates Title Organisation / Department
1/3/2018 - 1/4/2018 Visiting Research Scholar University of Oslo
Norway

Professional appointment

Dates Title Organisation / Department
1/3/2021 - 1/9/2021 BioCyc Curator SRI International (Macquarie University node)
Australia

Awards

Award

Year Award
2021 Vice-chancellor’s Commendation for Academic Excellence
Macquarie University
2019 NSW-ACT Nancy Millis Finalist
Australian Society for Microbiology
Edit

Publications

For publications that are currently unpublished or in-press, details are shown in italics.


Journal article (12 outputs)

Year Citation Altmetrics Link
2023 Li L, Short FL, Hassan KA, Naidu V, Pokhrel A, Nagy SS, et al., 'Systematic analyses identify modes of action of ten clinically relevant biocides and antibiotic antagonism in
DOI 10.1038/s41564-023-01474-z
Citations Scopus - 2Web of Science - 1
Co-authors Karl Hassan
2023 Naidu V, Shah B, Maher C, Paulsen IT, Hassan KA, 'AadT, a new weapon in
DOI 10.1099/mic.0.001341
Citations Scopus - 1
Co-authors Karl Hassan
2023 Naidu V, Bartczak A, Brzoska AJ, Lewis P, Eijkelkamp BA, Paulsen IT, et al., 'Evolution of RND efflux pumps in the development of a successful pathogen', Drug Resistance Updates, 66 (2023) [C1]

Aims: This study examined the origins and evolution of the AdeABC, AdeFGH and AdeIJK efflux pumps in the Acinetobacter genus, including human and animal pathogens and species from... [more]

Aims: This study examined the origins and evolution of the AdeABC, AdeFGH and AdeIJK efflux pumps in the Acinetobacter genus, including human and animal pathogens and species from non-clinical environments. Methods: Comparative genome analyses were performed using the reference sequences for 70 Acinetobacter species to identify putative orthologs of AdeABC, AdeFGH and AdeIJK and their regulators. Sequence similarities and the genomic locations of coding sequences were correlated with phylogeny to infer modes of evolution. Intraspecies variation was assessed in species of interest using up to 236 complete genome sequences. Mutants overproducing adeIJK in A. baylyi were examined to identify regulators of this system in a non A. baumannii species. Results: The results indicate that adeIJK has been a stable part of Acinetobacter genomes since the genesis of this genus, whereas adeABC and adeFGH were carried by less than half of the species, but showed some lineage specificity. The organisation and local genetic contexts of adeABC loci were particularly variable to the sub-species level, suggesting frequent recombination. Cognate regulatory systems were almost always found in the genomes of species encoding pumps. Mutations in adeN, which encodes a repressor of adeIJK, were selected by antibiotic exposure in A. baylyi, similar to previous findings in pathogenic lineages. Conclusions: The multidrug efflux capacity of clinical Acinetobacter strains stems from accessory and core genetic features. AdeIJK is likely to have ancient core function(s) that have promoted its maintenance, whereas recent antibiotic use may be driving the evolution of the AdeABC pump.

DOI 10.1016/j.drup.2022.100911
Citations Scopus - 6
Co-authors Peter Lewis, Karl Hassan
2022 Naidu V, Hyde L, Eijkelkamp BA, Megharaj M, Subashchandrabose S, Hassan KA, 'Complete Genome Sequence of Rhodococcus sp. Strain 9, Isolated from Contaminated Australian Groundwater', MICROBIOLOGY RESOURCE ANNOUNCEMENTS, 11 (2022)
DOI 10.1128/mra.00317-22
Co-authors Karl Hassan, Suresh Subashchandrabose, Megh Mallavarapu
2021 Naidu V, Shah B, Kamath KS, Chien A, Nagy S, Pokhrel A, et al., 'Identification of a novel ciprofloxacin tolerance gene, aciT, which contributes to filamentation in acinetobacter baumannii', Antimicrobial Agents and Chemotherapy, 65 (2021) [C1]

Fluoroquinolones are one of the most prescribed broad-spectrum antibiotics. However, their effectiveness is being compromised by high rates of resistance in clinically important o... [more]

Fluoroquinolones are one of the most prescribed broad-spectrum antibiotics. However, their effectiveness is being compromised by high rates of resistance in clinically important organisms, including Acinetobacter baumannii. We sought to investigate the transcriptomic and proteomic responses of the clinical A. baumannii strain AB5075-UW upon exposure to subinhibitory concentrations of ciprofloxacin. Our transcriptomics and proteomics analyses found that the most highly expressed genes and proteins were components of the intact prophage phiOXA. The next most highly expressed gene (and its protein product) under ciprofloxacin stress was a hypothetical gene, ABUW_0098, named here the Acinetobacter ciprofloxacin tolerance (aciT) gene. Disruption of this gene resulted in higher susceptibility to ciprofloxacin, and complementation of the mutant with a cloned aciT gene restored ciprofloxacin tolerance to parental strain levels. Microscopy studies revealed that aciT is essential for filamentation during ciprofloxacin stress in A. baumannii. Sequence analysis of aciT indicates the encoded protein is likely to be localized to the cell membrane. Orthologs of aciT are found widely in the genomes of species from the Moraxellaceae family and are well conserved in Acinetobacter species, suggesting an important role. With these findings taken together, this study has identified a new gene conferring tolerance to ciprofloxacin, likely by enabling filamentation in response to the antibiotic.

DOI 10.1128/AAC.01400-20
Citations Scopus - 7Web of Science - 3
Co-authors Karl Hassan
2021 Zang M, Macdermott-Opeskin H, Adams FG, Naidu V, Waters JK, Carey AB, et al., 'The membrane composition defines the spatial organization and function of a major acinetobacter baumannii drug efflux system', mBio, 12 (2021) [C1]

Acinetobacter baumannii is one of the world¿s most problematic nosoco-mial pathogens. The combination of its intrinsic resistance and ability to acquire resistance markers allow t... [more]

Acinetobacter baumannii is one of the world¿s most problematic nosoco-mial pathogens. The combination of its intrinsic resistance and ability to acquire resistance markers allow this organism to adjust to antibiotic treatment. Despite being the primary barrier against antibiotic stress, our understanding of the A. baumannii membrane composition and its impact on resistance remains limited. In this study, we explored how the incorporation of host-derived polyunsaturated fatty acids (PUFAs) is associated with increased antibiotic susceptibility. Functional analyses of primary A. baumannii efflux systems indicated that AdeB-mediated antibiotic resistance was impacted by PUFA treatment. Molecular dynamics simulations of AdeB identified a specific morphological disruption of AdeB when positioned in the PUFA-enriched membrane. Collectively, we have shown that PUFAs can impact antibiotic efficacy via a vital relationship with antibiotic efflux pumps. Furthermore, this work has revealed that A. baumannii¿s unconditional desire for fatty acids may present a possible weakness in its multidrug resistance capacity. IMPORTANCE Antimicrobial resistance is an emerging global health crisis. Consequently, we have a critical need to prolong our current arsenal of antibiotics, in addition to the development of novel treatment options. Due to their relatively high abundance at the host-pathogen interface, PUFAs and other fatty acid species not commonly synthesized by A. baumannii maybeactivelyacquiredbyA. bau-mannii during infection and change the biophysical properties of the membrane beyond that studied in standard laboratory culturing media. Our work illustrates how the membrane phospholipid composition impacts membrane protein function, which includes an important multidrug efflux system in extensively-drug-resistant A. baumannii. This work emphasizes the need to consider including host-derived fatty acids in in vitro analyses of A. baumannii. Onabroaderscope, this study presents new findings on the potential health benefits of PUFA in indi-viduals at risk of contracting A. baumannii infections or those undergoing antibiotic treatment.

DOI 10.1128/mBio.01070-21
Citations Scopus - 13Web of Science - 3
Co-authors Karl Hassan
2021 Short FL, Liu Q, Shah B, Clift HE, Naidu V, Li L, et al., 'The Acinetobacter baumannii disinfectant resistance protein, AmvA, is a spermidine and spermine efflux pump', Communications Biology, 4 (2021) [C1]

Antimicrobial resistance genes, including multidrug efflux pumps, evolved long before the ubiquitous use of antimicrobials in medicine and infection control. Multidrug efflux pump... [more]

Antimicrobial resistance genes, including multidrug efflux pumps, evolved long before the ubiquitous use of antimicrobials in medicine and infection control. Multidrug efflux pumps often transport metabolites, signals and host-derived molecules in addition to antibiotics or biocides. Understanding their ancestral physiological roles could inform the development of strategies to subvert their activity. In this study, we investigated the response of Acinetobacter baumannii to polyamines, a widespread, abundant class of amino acid-derived metabolites, which led us to identify long-chain polyamines as natural substrates of the disinfectant efflux pump AmvA. Loss of amvA dramatically reduced tolerance to long-chain polyamines, and these molecules induce expression of amvA through binding to its cognate regulator AmvR. A second clinically-important efflux pump, AdeABC, also contributed to polyamine tolerance. Our results suggest that the disinfectant resistance capability that allows A. baumannii to survive in hospitals may have evolutionary origins in the transport of polyamine metabolites.

DOI 10.1038/s42003-021-02629-6
Citations Scopus - 15Web of Science - 11
Co-authors Karl Hassan
2020 Li L, Hassan KA, Tetu SG, Naidu V, Pokhrel A, Cain AK, Paulsen IT, 'The Transcriptomic Signature of Tigecycline in Acinetobacter baumannii', Frontiers in Microbiology, 11 (2020) [C1]

Tigecycline, a protein translation inhibitor, is a treatment of last resort for infections caused by the opportunistic multidrug resistance human pathogen Acinetobacter baumannii.... [more]

Tigecycline, a protein translation inhibitor, is a treatment of last resort for infections caused by the opportunistic multidrug resistance human pathogen Acinetobacter baumannii. However, strains resistant to tigecycline were reported not long after its clinical introduction. Translation inhibitor antibiotics perturb ribosome function and induce the reduction of (p)ppGpp, an alarmone involved in the stringent response that negatively modulates ribosome production. Through RNA sequencing, this study revealed a significant reduction in the transcription of genes in citric acid cycle and cell respiration, suggesting tigecycline inhibits or slows down bacterial growth. Our results indicated that the drug-induced reduction of (p)ppGpp level promoted the production but diminished the degradation of ribosomes, which mitigates the translational inhibition effect by tigecycline. The reduction of (p)ppGpp also led to a decrease of transcription coupled nucleotide excision repair which likely increases the chances of development of tigecycline resistant mutants. Increased expression of genes linked to horizontal gene transfer were also observed. The most upregulated gene, rtcB, involving in RNA repair, is either a direct tigecycline stress response or is in response to the transcription de-repression of a toxin-antitoxin system. The most down-regulated genes encode two ß-lactamases, which is a possible by-product of tigecycline-induced reduction in transcription of genes associated with peptidoglycan biogenesis. This transcriptomics study provides a global genetic view of why A. baumannii is able to rapidly develop tigecycline resistance.

DOI 10.3389/fmicb.2020.565438
Citations Scopus - 9Web of Science - 7
Co-authors Karl Hassan
2020 Alquethamy SF, Adams FG, Naidu V, Khorvash M, Pederick VG, Zang M, et al., 'The Role of Zinc Efflux during Acinetobacter baumannii Infection', ACS Infectious Diseases, 6 150-158 (2020) [C1]
DOI 10.1021/acsinfecdis.9b00351
Citations Scopus - 19Web of Science - 14
Co-authors Karl Hassan
2019 Jiang JH, Hassan KA, Begg SL, Rupasinghe TWT, Naidu V, Pederick VG, et al., 'Identification of Novel Acinetobacter baumannii Host Fatty Acid Stress Adaptation Strategies', mBio, 10 (2019) [C1]
DOI 10.1128/mBio.02056-18
Citations Scopus - 40Web of Science - 25
Co-authors Karl Hassan
2019 Hassan KA, Naidu V, Edgerton JR, Mettrick KA, Liu Q, Fahmy L, et al., 'Short-chain diamines are the physiological substrates of PACE family efflux pumps', PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 116 18015-18020 (2019) [C1]
DOI 10.1073/pnas.1901591116
Citations Scopus - 18Web of Science - 15
Co-authors Karl Hassan
2018 Hassan KA, Liu Q, Elbourne LDH, Ahmad I, Sharples D, Naidu V, et al., 'Pacing across the membrane: the novel PACE family of efflux pumps is widespread in Gram-negative pathogens', Research in Microbiology, 169 450-454 (2018) [C1]
DOI 10.1016/j.resmic.2018.01.001
Citations Scopus - 70Web of Science - 61
Co-authors Karl Hassan
Show 9 more journal articles

Preprint (1 outputs)

Year Citation Altmetrics Link
2023 Naidu V, Shah B, Maher C, Paulsen IT, Hassan KA, 'AedG, a new weapon in
DOI 10.1101/2023.01.03.522653
Co-authors Karl Hassan
Edit

Grants and Funding

Summary

Number of grants 9
Total funding $226,776

Click on a grant title below to expand the full details for that specific grant.


20235 grants / $119,776

Dial-on-demand: Engineering efflux pumps for microbial cell factories$25,000

Funding body: ARC (Australian Research Council)

Funding body ARC (Australian Research Council)
Project Team

Dr. Bhumika Shah, Dr. Varsha Naidu, Dr. Jonathan Weinstein, Associate Professor Karl Hassan, Associate Professor Sarel Fleishman, Professor Ian Paulsen

Scheme ARC Centres of Excellence
Role Investigator
Funding Start 2023
Funding Finish 2024
GNo
Type Of Funding C1200 - Aust Competitive - ARC
Category 1200
UON N

Transport protein discovery and engineering for industrial biotechnology$25,000

Funding body: ARC (Australian Research Council)

Funding body ARC (Australian Research Council)
Project Team

Dr. Varsha Naidu, Dr. Verlaine Timms, Dr. Liping Li, Dr. Lucie Semenec, Professor Ian Paulsen, Associate Professor Karl Hassan

Scheme ARC Centres of Excellence
Role Lead
Funding Start 2023
Funding Finish 2024
GNo
Type Of Funding C1200 - Aust Competitive - ARC
Category 1200
UON N

A versatile and straightforward new method for evaluating protein-protein interactions and conformational changes$25,000

Funding body: ARC (Australian Research Council)

Funding body ARC (Australian Research Council)
Project Team

Dr. Estefania Giannini, Dr. Varsha Naidu, Dr. Axayacatl Garcia, Dr. Bhumika Shah, Dr. Victoria Barja, Sasha Gohar, Prof. Ian Paulsen, Dr. Briardo Llorente

Scheme ARC Centres of Excellence
Role Investigator
Funding Start 2023
Funding Finish 2024
GNo
Type Of Funding C1200 - Aust Competitive - ARC
Category 1200
UON N

Illuminating the first steps of endosymbiosis: transcriptomics and metabolomics analyses of synthetic symbionts$25,000

Funding body: Bioplatforms Australia

Funding body Bioplatforms Australia
Project Team

Dr Victoria Barja, Dr Esteban Marcelin, Dr Varsha Naidu, Sam Clay, Dr Dayane Costa, Dr Estefania Giannini, Professor Ian Paulsen, Dr Briardo Liorente

Scheme BPA OMICS RESEARCH PROJECT FUNDING SCHEME
Role Investigator
Funding Start 2023
Funding Finish 2023
GNo
Type Of Funding C1200 - Aust Competitive - ARC
Category 1200
UON N

Transport protein discovery and engineering for industrial biotechnology$19,776

Funding body: ARC Centre of Excellence in Synthetic Biology (CoESB)

Funding body ARC Centre of Excellence in Synthetic Biology (CoESB)
Project Team Doctor Varsha Naidu, Associate Professor Karl Hassan, Doctor Liping Li, Professor Ian Paulsen, Doctor Lucie Semenec, Doctor Verlaine Timms
Scheme EMCR Seed Funding Scheme
Role Lead
Funding Start 2023
Funding Finish 2023
GNo G2300392
Type Of Funding C1200 - Aust Competitive - ARC
Category 1200
UON Y

20221 grants / $25,000

Biosensor design & construction, Strain Construction Transposon library construction, TraDISense’n’Sort, Microbial Community design$25,000

Funding body: Bioplatforms Australia

Funding body Bioplatforms Australia
Project Team

Karl Hassan, Evan Gibbs, Varsha Naidu, Amy Cain, Ian Paulsen, Brett Neilan

Scheme BPA OMICS RESEARCH PROJECT FUNDING SCHEME
Role Investigator
Funding Start 2022
Funding Finish 2022
GNo
Type Of Funding C1200 - Aust Competitive - ARC
Category 1200
UON N

20182 grants / $7,000

Macquarie University Postgraduate Research Fund (PGRF) Travel Award$5,000

Funding body: Travel grant

Funding body Travel grant
Scheme Macquarie University
Role Lead
Funding Start 2018
Funding Finish 2018
GNo
Type Of Funding External
Category EXTE
UON N

European Molecular Biology Laboratory (EMBL) Travel Award$2,000

A short-term travel grant awarded to enrol in a bioinformatics course at the European Bioinformatics Institute (EBI) in Cambridge, UK. 

Funding body: European Molecular Biology Laboratory (EMBL)

Funding body European Molecular Biology Laboratory (EMBL)
Scheme European Molecular Biology Laboratory (EMBL) Travel Award
Role Lead
Funding Start 2018
Funding Finish 2018
GNo
Type Of Funding International - Competitive
Category 3IFA
UON N

20161 grants / $75,000

Australian Government Research Training Program (RTP) Award$75,000

Funding body: Australian Government

Funding body Australian Government
Project Team

Varsha Naidu

Scheme Australian Government
Role Lead
Funding Start 2016
Funding Finish 2019
GNo
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON N
Edit

Research Collaborations

The map is a representation of a researchers co-authorship with collaborators across the globe. The map displays the number of publications against a country, where there is at least one co-author based in that country. Data is sourced from the University of Newcastle research publication management system (NURO) and may not fully represent the authors complete body of work.

Country Count of Publications
Australia 12
United Kingdom 3
Finland 1
United States 1
Edit

Dr Varsha Naidu

Position

Post Doctoral Researcher
School of Environmental and Life Sciences
College of Engineering, Science and Environment

Contact Details

Email varsha.naidu@newcastle.edu.au
Link Personal Blogs
Edit